Glooko logo

Glooko Blog

Glooko Launches Sleek New Mobile App Design to Make Diabetes Management Easier

Glooko Mobile App RedesignGlooko Mobile App Home Screen for People with Diabetes

​​Today, we launched a sleek new look to the Glooko® Mobile App, which makes it easier for users with diabetes to navigate, organize their data in one place and share their data with their doctor and extended care team. We’ve also streamlined data visualization, so users can seamlessly view all their data at once.

The modern look and feel of the Home screen allows for quick access to the user’s most used actions, including seeing glucose trends, logging medication, and tracking food and exercise.

For new mobile app users getting started with Glooko, we’ve simplified the onboarding process and customized it to fit individual goals.

From easily connecting to their clinics and sharing reports with their care team to using the Quick Add slider to conveniently add food, insulin and exercise, the free Glooko Mobile App, available in the App Store and Google Play Store, goes where people with diabetes go.

Wondering what went into the redesign of our digital health app? We sat down with some of the Glooko team members, including Director of Product Design Amanda Martin, Product Designer Ben Stone and Product Manager Chase Sutton, who worked behind-the-scenes to learn more about the process.

Glooko Product Design Team

What were the goals and motivation behind the Glooko Home screen’s new look? How did you decide what features to highlight in the Home screen?

Glooko Mobile App Health Data for People with DiabetesWhile we always take into account feedback from our users, our team performed extensive research and interviews to see what opportunities existed for changes in the app that would result in the greatest improvements. Through this, we landed on focusing our efforts mostly on the Home screen, the onboarding process for new users, and modernizing the user experience.

In this high-impact space, we reimagined how to display insights for users through side-by-side and detailed charts and graphs with all the pertinent data, including its sources, in one place. We added Quick Add buttons for easily tracking food, insulin, medication and other actions important to people with diabetes.

Through our interviews, we learned that users like to feel connected to their doctors and care teams and view that as a major benefit of Glooko. We wanted our users to have a direct link to them, so we added to the Home screen an easy way to reach and share data with them.

We also learned that we needed to improve the onboarding experience by making it quicker to get started and sync diabetes devices. This process was a hurdle for users in the past and we sought to simplify it in the redesign. There’s now a space on the Home screen for new users who are looking to get started with Glooko.

What are some of the main takeaways from the redesign of the Glooko Mobile App? How will this help current and new users?

For both current and new users of Glooko, the updated navigation on the Home screen helps users access key features more efficiently as the older version had many features tucked away and hard to discover. We put popular features, like food logging and sharing data with care teams, front and center on the Home screen—all available with one scroll and featuring the latest synced data.

For new users, we really wanted to give them an easy onboarding experience. We learned that the earlier version of the Glooko app’s onboarding was somewhat complicated and could be viewed as a turn off for people just joining and looking to take full advantage of our digital health app.

The reimagined onboarding is guided and shows new users what to do in a very organized, “bite-sized” way that allows them to easily complete it at their own pace.

What’s the new onboarding process like? Is it easier and does it have less steps for new users?

We learned through our interviews that the onboarding process definitely needed an overhaul. Users would go to the first step of syncing their device and then never went any further with the process as they found it too difficult. Our takeaway was that we needed to get new users to the Home screen right away.

In the new process, users now start on the Home screen and can complete the onboarding tracker, which includes syncing their device, tracking their insulin and completing their Glooko profile, in any order and timeframe. Users now get to experience all the features of Glooko right out of the gate!

Glooko Onboarding Process for People with Diabetes

How did you take feedback from people living with diabetes when making these changes that improve the experience of the Glooko Mobile App?

Connecting with users and hearing from them is incredibly important to our design process.

We have a human-centered design team, so it was integral that we talked to actual Glooko users to hear their feedback. We took what we learned and brought sketches and concepts for improving the Glooko Mobile App back to them. It’s a cycle that we go through all the time, but one that we really valued in this project.

Our team had some great conversations during this process with users who synced once to those who were very active in the app and constantly logging food. Each user group who provided us with feedback helped inform our decisions in the redesign.

We also used insights from data in the app to verify our theories around user engagement during these interviews.

What’s some of the feedback you’ve received from test users on the new look?

Glooko Mobile App Weekly Overview for People with DiabetesThey’ve all been very excited about the improvements to the Glooko Mobile App.

We’ve received the most feedback about the modern look and feel, responsiveness and colors. Users are also pleased with the personalized way the data is displayed, whether it’s a continuous glucose meter, blood glucose meter or other compatible device.

The simplified, consistent and clean approach to the new experience will continue to resonate with our users—new and existing.

What other changes will be coming in the future to the Glooko Mobile App?

We have an ambitious and exciting roadmap for the mobile app, and much of it is focused on data.

We want users to better understand their overall health, so we’re looking to develop innovative and detailed charts and graphs to enable the next-generation of diabetes insights. These new data insights will give people with diabetes and their care teams the ability to make smarter decisions to improve their health.

Additionally, we’ll introduce personalized nudges that will help encourage behavior change and guide users to better lifestyle decisions in the coming future.

While all these future upgrades are very exciting, we’re giving both people with diabetes and their doctors the ability to see the power of Glooko and what connected care really is in our new reimagined version today.

The Glooko app is now available in the App Store and Google Play Store.

MKT-0434 01

Insulet’s Omnipod 5 Compatible with Glooko

Glooko Insulet Omnipod 5

Glooko is excited to share that our digital health platform for people with diabetes and related chronic conditions is compatible in the United States with Insulet Corporation’s Omnipod® 5 Automated Insulin Delivery (AID) System.

The automated insulin delivery system, which is composed of the Omnipod 5 App, the Pod and has Dexcom® G6 Continuous Glucose Monitor (CGM) System integration, received FDA clearance for use by individuals ages 2 and older with type 1 diabetes in 2022.

As the first tubeless AID system with smartphone control* in the U.S., Omnipod 5 integrates with the Dexcom G6 CGM System to automatically adjust insulin, help protect against highs and lows in glucose levels**, and simplify life for people with diabetes. The system’s innovative Pod uses SmartAdjust™ technology that continuously and automatically regulates insulin delivery based on a patient’s customized Target Glucose.

“With the many benefits provided by the Omnipod 5, we’re thrilled it’s compatible and available to Glooko users in the U.S.,” said David Conn, Glooko’s Executive Vice President of Partnerships and Alliances. “Our partnership with Insulet allowed us to be compatible from launch with this innovative new AID system designed for people looking to better manage their diabetes.”

Through our integration with Insulet, patients using the Omnipod 5 can connect their system to Glooko and upload their data from home via a cloud connection, expediting the time spent with healthcare providers. Healthcare providers can review the data uploaded and view standardized, comprehensive reports in the Glooko dashboard to help gain insights and make decisions to optimize care.

“The team at Insulet appreciates the support Glooko provided to make the launch of the Omnipod 5 possible and successful,” said Dr. Trang Ly, MBBS, FRACP, Ph.D., Senior Vice President and Medical Director, Insulet. “This System has been life-changing for so many people living with type I diabetes and we look forward to continuing to see its impact.”

Along with the Omnipod 5, the Glooko platform is also compatible with Insulet Corporation’s Omnipod DASH®.

At Glooko, we’re continuously increasing the number of devices that are compatible with our digital health platform, and over 3 million users around the globe have benefited in managing their health with our tools. We’re currently compatible with a majority of global diabetes and health monitoring devices on the market, which gives patients and their healthcare providers flexibility in managing their diabetes and related chronic conditions.

*For a list of compatible smartphone devices visit omnipod.com/compatibility

**Study in 240 people with T1D aged 6 – 70 years involving 2 weeks standard diabetes therapy followed by 3 months Omnipod 5 use in Automated Mode. Average time with high blood glucose in adults/adolescents and children, standard therapy vs. 3-month Omnipod 5: 32.4% vs. 24.7%; 45.3% vs. 30.2%. Median time with low blood glucose in adults/adolescents and children, standard therapy vs. 3-mo Omnipod 5: 2.0% vs. 1.1%; 1.4% vs. 1.5%. Brown et al. Diabetes Care (2021).

Study in 80 people with T1D aged 2 – 5.9 years involving 2 weeks standard diabetes therapy followed by 3 months Omnipod 5 use in Automated Mode. Average time in Target Glucose range (from CGM) for standard therapy vs Omnipod 5 = 57.2% vs. 68.1%. Average time in Target Glucose range (12AM -< 6AM) from CGM in standard therapy vs. Omnipod 5 = 58.2% vs 81.0%. Average A1c in standard therapy vs. Omnipod 5 = 7.4% vs. 6.9%. Median time with low blood glucose from CGM: standard therapy = 3.43% vs. 2.46%. Sherr JL, et al. Diabetes Care (2022).

MKT-0358 01

Glooko Mobile App Simplifies Tracking Food Intake for People with Diabetes

Glooko Mobile App Food Tracker for Diabetes

​​Tracking Food Intake in the Glooko Mobile App for DiabetesFood is a critical component in the management of diabetes.

​​People with diabetes can use the Glooko mobile app, available in the App Store and Google Play Store, to easily log their food intake and keep a historical account of how food affects their chronic condition.

The data from daily meals can be viewed alongside data from compatible diabetes and health monitoring devices, medications and insulin to reveal trends and patterns to better understand what is affecting a person’s diabetes

Tracking food consumption in our digital health app can be handled in multiple different ways, including by searching the food database, using voice capture or scanning a barcode.

The Food Tracker in the Glooko Mobile App for DiabetesThe Glooko mobile app simplifies tracking food consumption while allowing users to explore nutrition facts, including carbohydrates, calories, fats and proteins.

Frequent users of the food tracker can also create personalized custom food entries of their favorite meals, so they don’t need to re-add portions multiple times.

“The food tracker feature in our mobile app allows users to see how the food they’re consuming each day may affect their diabetes,” said Glooko Chief Product Officer Ed Marshall. “Being able to see all the data in one place gives users the ability to understand how they’re doing and make informed decisions about their health.”

Glooko Food Tracker for Diabetes

The Glooko mobile app and its food tracker feature is also constantly evolving to meet the needs of our global users.

To better support users in the U.K., France, Germany and Spain last year, we added unique regional food items that are searchable in British English, French, German and Spanish to our connected care app.

For handy ways on how to use the food tracker, follow along with healthy eating and living tips from Glooko’s resident dietitian, Bridget Wood, RD, LD, CDCES.

MKT-0417 01

New Food Database Languages and Regional Items in the Glooko App Enable Users to Better Track Food Intake

New Food Database Languages and Regional Items in the Glooko App Enable Users to Better Track Food Intake

As we continue to expand around the globe, we’re also growing our support for languages of Glooko users with diabetes and related chronic conditions.

In Glooko Mobile Release Version 5.18, we updated our food database in our mobile app to better support users in the U.K., France, Germany and Spain. The app’s database, which has more than 500,000 items, now has new, unique regional food items that are searchable in British English, French, German and Spanish and offers users the ability to explore nutritional facts, including carbohydrates, calories, fats and proteins.

For people with diabetes, food is a critical component in the management of their condition. The update to the Glooko food database helps users better track food intake by enabling them to log a wider variety of food items in four new languages via the mobile app and keep a historical account of how food affects their condition.

In addition to manually searching the database and selecting a food item to track, users can also log food in our mobile app by using voice capture, a feature not available in many of the leading food tracking apps, or the barcode scanner.

Alongside information about their food intake, users are able to see all their synced data from their meter, insulin pump or pen, CGM, food app, activity tracker and blood pressure device in one place and make more informed decisions about their health.

For full details on all the updates in our Mobile Release Version 5.18, click here.

MKT-0344 01

Glooko Adds New Enhancements to Billing Export Feature to Streamline Submitting CPT Codes for Remote Patient Monitoring Reimbursement

Glooko Adds New Enhancements to Billing Export Feature to Streamline Submitting CPT Codes for Remote Patient Monitoring Reimbursement

Glooko recently introduced new enhancements to the billing export feature in Population Health Analytics for professional users with Glooko Enterprise accounts. The new features provide healthcare providers and care teams supporting patients with diabetes and related chronic conditions the information needed to properly bill CPT codes for remote patient monitoring (RPM) activities.

This evolution of Population Health Analytics, a tool available in our Glooko platform that creates advanced filters on patient populations, targets at-risk patients and tracks statistics post-intervention, now allows care teams to better serve their patients and helps them easily determine which patients are eligible for RPM reimbursement for a given calendar month.

These new enhancements provide dates of first in-clinic upload, any in-clinic uploads present during the selected date range and now clearly defined data for the completion of 16 days of remote data uploads required to meet billing requirements. Users will now see two columns added to their billing export CSV file for the information needed to bill for RPM within a calendar month.

“These enhancements provide healthcare providers and care teams using our digital health platform with the information needed to more efficiently and easily bill for RPM using the proper CPT codes,” said Glooko Chief Commercial Officer Zach Henderson. “We’re proud of Team Glooko’s efforts to create a more streamlined and quicker process for busy care teams seeking reimbursement using billing codes that support RPM efforts aimed at improving care for people with diabetes and related chronic conditions.”

In the recent 2022 Final Rule, Centers for Medicare and Medicaid Services (CMS) showed support for telehealth and RPM with five updated billing codes.

  • 99543: Initial setup of the device, including patient education on use of equipment for RPM.

  • 99454: Monthly remote monitoring with daily recordings. Billed each calendar month and must have a minimum of 16 days of remotely uploaded data.

  • 99457: Monitoring and treatment management, which requires interactive communication between the patient and caregiver for the first 20 minutes during the calendar month.

  • 99458: Each additional 20 minutes of interactive communication between the patient and caregiver during the calendar month.

  • 99091: The time it takes for qualified clinical staff to gather, interpret and process monitoring data, at least 30 minutes every 30 days.

For more information on reimbursement payments and to learn how the Glooko digital health platform provides a better economic value to healthcare providers, contact Team Glooko or download a PDF on our new Population Health Billing Export Feature.

Per CMS policy on reimbursements, patients must agree and opt-in to be enrolled in an RPM program to qualify for the minimum of 16 days of data captured in a 30-day period. Not all payers reimburse for CPT RPM. Reimbursement policies vary by state and payer, please consult your billing specialist on policies for your local area or region.

MKT-0343 01

Glooko Adds SOC 2 Type 1 Certification to its Growing Data Security and Privacy Accreditations

SOC 2 Type 1 Certification Glooko

At Glooko, we’re committed to the security of personal data and protected health information. Through certifications from key global organizations, we’ve established both privacy protection and data security as critical, high-priority parts of our processes, practices and culture.

We’re proud to announce that Glooko is now SOC 2 Type 1 certified. This comprehensive reporting standard established by the American Institute of Certified Public Accountants was verified through independent validation and attests that Glooko has all the required controls in place for its people, systems and processes to ensure the security of its customers’ data as well as the company’s own software.

“Adding SOC 2 Type 1 certification alongside our existing HITRUST CSF certification provides additional assurance to our current and prospective customers that we’re in compliance with leading industry standards and their data is safe,” said Greg Omundson, technical project manager at Glooko. “We couldn’t have achieved this certification without the hard work of Team Glooko and their ongoing commitment to the security and privacy of data from customers.”

Over the coming months, we’ll continue to work toward achieving certifications from other leading global security and privacy organizations.

Glooko Release 21.4 Brings Localized Unit of Measurement, Additional Data and Expanded Device Compatibility

Glooko Release 21.4

At Glooko, we’re always innovating and expanding the features of our platform for people with diabetes and chronic conditions. Through user research, we’ve implemented a series of updates in Glooko Release 21.4 for professional and personal users.

“In this release, we wanted to ensure patients using our digital health platform were having a more seamless experience and healthcare providers could access more powerful analytics,” said Sebastian Dreijer, Glooko’s director of product management for EMEA. “By introducing a default localized unit of measurement feature and additional devices compatible with Glooko, we’re expanding our reach globally while adapting our features to meet the needs of local markets.”

To simplify Glooko account set-up for healthcare providers and patients, newly created accounts will now default to the local unit of measurement. Patients who register with Glooko directly will have their unit of measurement set to the default for their country of residence, while patients who have their account created in a clinic will have their unit of measurement set to the clinic’s defined unit of measure. These settings can also be adjusted in your Glooko account profile.

Glooko Tandem LGS PLGS

For healthcare providers, care teams and people with diabetes using Tandem Basal-IQ and Control-IQ, there is now additional data available, including a bi-hourly analysis detailing the percentage of LGS/PLGS suspended and the number of suspensions for each bihourly segment, as well as additional insulin information. The Overview graph for a 1-day time period will now detail the amount of scheduled basal insulin units and include the number of units for both bolus and basal insulin on the insulin pie chart.

Additionally, we have expanded Glooko’s device compatibility to include:

  • Ypsomed Mylife Cloud: It is now possible to connect a Mylife Cloud account to Glooko for wireless syncing

  • Abbott Freestyle Libre (Sweden/Norway Only): The Freestyle Libre can now be uploaded via both Transmitter and Glooko Uploader

  • Abbott Freestyle Libre 2 (Sweden/Norway Only): The Freestyle Libre 2 can now be uploaded via the Glooko Uploader

With the human body turning carbohydrates into glucose, blood sugar levels rise when you eat foods with carbohydrates. That’s why we’ve updated the Carb Display on the Overview graph on the Glooko Web App to make it easier to see manually entered carbs and device synced carbs within the Carbs section. Carb entries entered within 10 minutes of each other will now be grouped together and each carb entry is visible when hovering over the value on the graph.

Glooko Parental Guardian Consent

For patients using Glooko, account creation for minors in some regional jurisdictions now requires a parent or guardian email to be added during the registration process. Consent agreements will be sent to the parent or guardian email entered during registration. Once the parent or guardian reviews and accepts the consent and selects ‘Activate Account,’ the minor can access and utilize his or her Glooko account.

For the full release notes, click here.

Have a question for our customer support team? Visit the Help Center, or email [email protected] (North America) or [email protected] (Europe).